DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer-Reference-Cited by-同舟云学术

DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer

Published:2022-03-04 Issue: Volume:13 Page:
ISSN:1664-8021
Container-title:Frontiers in Genetics
language:
Short-container-title:Front. Genet.

Author:

Zeng Yunqing,Rong Huimin,Xu Jianwei,Cao Ruyue,Li Shuhua,Gao Yanjing,Cheng Baoquan,Zhou Tao

Abstract

Gastric cancer (GC) is a very common malignancy with a poor prognosis, and its occurrence and development are closely related to epigenetic modifications. Methylation of DNA before or during gastric cancer is an interesting research topic. This article reviews the studies on DNA methylation related to the cause, diagnosis, treatment, and prognosis of gastric cancer and aims to find cancer biomarkers to solve major human health problems.

Funder

Key Technology Research and Development Program of Shandong

Publisher

Frontiers Media SA

Subject

Genetics (clinical),Genetics,Molecular Medicine

Reference121 articles.

1. P16 Promoter Hypermethylation: A Useful Serum Marker for Early Detection of Gastric Cancer;Abbaszadegan;World J. Gastroenterol.,2008

2. The Reprimo-like Gene Is an Epigenetic-Mediated Tumor Suppressor and a Candidate Biomarker for the Non-invasive Detection of Gastric Cancer;Alarcón;Int. J. Mol. Sci.,2020

3. Promoter Methylation of DNA Repair Genes Predicts Disease-free Survival of Gastric Adenocarcinoma after Adjuvant Radiotherapy;An;Mol. Ther. Oncolytics,2020

4. Assessment of SOX17 DNA Methylation in Cell Free DNA from Patients with Operable Gastric Cancer. Association with Prognostic Variables and Survival;Balgkouranidou;Clin. Chem. Lab. Med.,2013

5. Prognostic Role of APC and RASSF1A Promoter Methylation Status in Cell Free Circulating DNA of Operable Gastric Cancer Patients;Balgkouranidou;Mutat. Research/Fundamental Mol. Mech. Mutagenesis,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MIR124-3 and NKX6-1 hypermethylation profiles accurately predict metachronous gastric lesions in a Caucasian population;Clinical Epigenetics;2024-08-21

2. Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma;Nature Communications;2024-08-09

3. Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor;Journal of Personalized Medicine;2024-02-20

4. mRNA Expression and Methylation of the RAD51, ATM, ATR, BRCA1, and BRCA2 Genes in Gastric Adenocarcinoma;Biomarker Insights;2024-01

5. Antiproliferative, apoptosis-inducing, and GSTP1 demethylation activities of Ellagitannins isolated from Cornus alba L.;Natural Product Research;2023-12-22